These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18565693)

  • 21. Predictors of residential treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; MacMaster SA; Seiters J
    J Psychoactive Drugs; 2013; 45(2):122-31. PubMed ID: 23909000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of nonmethadone outpatient treatment: results from a national survey.
    Friedmann PD; Alexander JA; Yey Y; Nahra T; Soliman S; Pollack HA
    Subst Abus; 2006 Sep; 27(3):47-53. PubMed ID: 17135180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retention of homeless clients in substance abuse treatment. Findings from the National Institute on Alcohol Abuse and Alcoholism Cooperative Agreement Program.
    Orwin RG; Garrison-Mogren R; Jacobs ML; Sonnefeld LJ
    J Subst Abuse Treat; 1999; 17(1-2):45-66. PubMed ID: 10435252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment needs and outcomes of two subtypes of homeless persons who abuse substances.
    Mavis BE; Humphreys K; Stöffelmayr BE
    Hosp Community Psychiatry; 1993 Dec; 44(12):1185-7. PubMed ID: 8132194
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis.
    Parthasarathy S; Weisner C; Hu TW; Moore C
    J Stud Alcohol; 2001 Jan; 62(1):89-97. PubMed ID: 11271969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substance abuse day treatment and managed health care.
    Schneider RJ; Herbert M
    J Ment Health Adm; 1992; 19(1):119-24. PubMed ID: 10171034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery from opioid addiction in DATOS.
    Flynn PM; Joe GW; Broome KM; Simpson DD; Brown BS
    J Subst Abuse Treat; 2003 Oct; 25(3):177-86. PubMed ID: 14670523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Which elements of improvement collaboratives are most effective? A cluster-randomized trial.
    Gustafson DH; Quanbeck AR; Robinson JM; Ford JH; Pulvermacher A; French MT; McConnell KJ; Batalden PB; Hoffman KA; McCarty D
    Addiction; 2013 Jun; 108(6):1145-57. PubMed ID: 23316787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distance traveled to outpatient drug treatment and client retention.
    Beardsley K; Wish ED; Fitzelle DB; O'Grady K; Arria AM
    J Subst Abuse Treat; 2003 Dec; 25(4):279-85. PubMed ID: 14693257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing the long-term sustainment of quality improvements made in addiction treatment facilities: a qualitative study.
    Stumbo SP; Ford JH; Green CA
    Addict Sci Clin Pract; 2017 Nov; 12(1):26. PubMed ID: 29089054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Who cares for involuntary clients?
    Soliman S; Pollack HA; Alexander JA
    Subst Abus; 2009; 30(1):1-13. PubMed ID: 19197777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.
    Grella CE; Hser YI; Huang YC
    Child Abuse Negl; 2006 Jan; 30(1):55-73. PubMed ID: 16406024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive validity of the ASAM Patient Placement Criteria for naturalistically matched vs. mismatched alcoholism patients.
    Magura S; Staines G; Kosanke N; Rosenblum A; Foote J; DeLuca A; Bali P
    Am J Addict; 2003; 12(5):386-97. PubMed ID: 14660153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adolescent substance abuse treatment clinicians' self-help meeting referral practices and adolescent attendance rates.
    Passetti LL; Godley SH
    J Psychoactive Drugs; 2008 Mar; 40(1):29-40. PubMed ID: 18472663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Hunkeler EM; Hu T; Selby JV
    Health Serv Res; 2000 Oct; 35(4):791-812. PubMed ID: 11055449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Access to inpatient or residential substance abuse treatment among homeless adults with alcohol or other drug use disorders.
    Wenzel SL; Audrey Burnam M; Koegel P; Morton SC; Miu A; Jinnett KJ; Greer Sullivan J
    Med Care; 2001 Nov; 39(11):1158-69. PubMed ID: 11606870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managed care and access to substance abuse treatment services.
    Alexander JA; Nahra TA; Wheeler JR
    J Behav Health Serv Res; 2003; 30(2):161-75. PubMed ID: 12710370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of managed care on substance abuse treatment: a problem in need of solution. A report of the American Society of Addiction Medicine.
    Galanter M; Keller DS; Dermatis H; Egelko S;
    Recent Dev Alcohol; 2001; 15():419-36. PubMed ID: 11449756
    [No Abstract]   [Full Text] [Related]  

  • 39. Problems in the application of the Addiction Severity Index (ASI) in rural substance abuse services.
    Wertz JS; Cleaveland BL; Stephens RS
    J Subst Abuse; 1995; 7(2):175-88. PubMed ID: 7580228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of health services use associated with Veterans Affairs outpatient substance-use treatment.
    Stecker T; Curran GM; Han X; Booth BM
    J Stud Alcohol Drugs; 2007 Jul; 68(4):510-8. PubMed ID: 17568954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.